| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/27/2001 | US6194547 ETS2 repressor factor (ERF) |
| 02/27/2001 | US6194546 Influenza virus haemagglutinin which has a heterologous epitope at antigenic site a; vaccines against foot-and-mouth disease, poliovirus, human rhinovirus, hepatitis b virus, plasmodium and bacteria |
| 02/27/2001 | US6194543 Dendritic polypeptides |
| 02/27/2001 | US6194542 Method of detecting cytomegalovirus (CMV) |
| 02/27/2001 | US6194389 Particle-mediated bombardment of DNA sequences into tissue to induce an immune response |
| 02/27/2001 | US6194385 Calcium-binding protein |
| 02/27/2001 | US6194383 Homologous cyclic amino-acid sequences having different fatty acid residues synthesized by actinoplanes sp.; peptide antibiotics, lipopeptides a 1437, a-m, effective against grampositive bacteria and glycopeptide-resistant strains |
| 02/27/2001 | US6194381 Therapeutic agent and method for feline AIDS virus infections and feline atopic dermatitis |
| 02/27/2001 | US6194380 Agents for promoting bone formation |
| 02/27/2001 | US6194377 Methods for treating nervous system pathophysiologies using glial growth factors |
| 02/27/2001 | US6194376 Method for modulating inflammatory response comprising administering morphogen |
| 02/27/2001 | US6194212 Increasing gene expression by transducing eukaryotic cells with retrovirus vector having heterologous gene linked to regulatory sequence and scaffold attachment region of human interferon-beta gene, allowing cells to rest and express gene |
| 02/27/2001 | US6194208 Modified milk growth factor |
| 02/27/2001 | US6194195 Pure culture; for production of hypotensive agents and therapies for asthma, cerebral apoplexy, angina pectoris, acute renal failure, cardiac infarction, and cerebral vasospasm |
| 02/27/2001 | US6194191 Method for the production and purification of adenoviral vectors |
| 02/27/2001 | US6194187 Apoptosis-inducing protein and gene encoding the same |
| 02/27/2001 | US6194186 Human protein kinase and kinase inhibitors |
| 02/27/2001 | US6194177 DNA encoding a hybrid heterodimeric protein |
| 02/27/2001 | US6194176 Recombinant expression of proteins from secretory cell lines |
| 02/27/2001 | US6194175 Nucleotide sequences coding suppressor of transcriptional activity; for treating adult respiratory distress syndrome, allograft rejection, asthma, arthritis, cancer and restenosis; anticarcinogenic agents |
| 02/27/2001 | US6194173 Binding proteins for phosphoinositides, GRP1 or general receptor 1 for phophoinositide |
| 02/27/2001 | US6194172 Cytokine designated lerk-6 |
| 02/27/2001 | US6194171 Also vectors, transformed cells; useful for expression in cells for the purposes of identifying agonists or antagonists of ataxin-2-binding protein function |
| 02/27/2001 | US6194170 MurF of Streptococcus pneumoniae |
| 02/27/2001 | US6194169 Enhanced expression of human platelet-derived growth factor in Pichia pastoris |
| 02/27/2001 | US6194166 Isolated dna; genetic engineering |
| 02/27/2001 | US6194163 Method for the quantitative measurement of human acute phase serum amyloid A protein; recombinant protein; specific antibody |
| 02/27/2001 | US6194162 Method of screening for compounds that bind P2x receptor |
| 02/27/2001 | US6194156 Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof |
| 02/27/2001 | US6194153 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 1 (PS-1) gene |
| 02/27/2001 | US6194152 Nucleotide sequences for the diagnosis and treatment of human urogenital cancers |
| 02/27/2001 | US6194151 Nucleotide sequences coding binding polypeptide; for the detection of modulators of tumor necrosis factor activity; for the treatment of cell proliferation and differentiation defects |
| 02/27/2001 | US6194147 Classification of human leukocyte antigens; amplifying human leukocyte antigen sequences, hybridizing probes and detecting nucleotide sequence hybrids, detecting impurities, calibrating products with control alleles |
| 02/27/2001 | US6194142 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/27/2001 | US6194140 HCV NS3 protein fragments having helicase activity and improved solubility |
| 02/27/2001 | US6194138 Method for flushing blood cells using gelatin |
| 02/27/2001 | US6193983 Equine herpesvirus glycoproteins |
| 02/27/2001 | US6193982 Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
| 02/27/2001 | US6193981 Methods and compositions for impairing multiplication of HIV-1 |
| 02/27/2001 | US6193979 Compositions comprising complement receptor type 1 molecules having carbohydrate structures that are selectin ligands |
| 02/27/2001 | US6193975 Use of potentilla erecta extract in the cosmetic and pharmaceutical field |
| 02/27/2001 | US6193972 Hybrid heterodimeric protein hormone |
| 02/27/2001 | US6193971 Dictyocaulus viviparus antigen for diagnosing lungworm infestation and for vaccination |
| 02/27/2001 | US6193966 Administering bispecific protein or peptide molecule, comprising a first binding determinate which binds to fc.alpha.receptor without being blocked by immunoglobulin a and second binding determinant which binds to target antigen |
| 02/27/2001 | US6193965 Administering therapeutically effective amount of reagent which modulates kinase activity for treating cell proliferative disorder associated with c-jun n-terminal kinase disorder, |
| 02/27/2001 | US6193948 Contacting sample with purified hu antigenic polypeptide to form complex between purified hu antigenic polypeptide and antibody, detecting presence of complex formed to detect antibody associated with paraneoplastic sensory neuronopathy |
| 02/27/2001 | CA2232789C Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 02/27/2001 | CA2104681C Mineralized collagen |
| 02/27/2001 | CA2101316C Gnrh analogs |
| 02/27/2001 | CA2025598C Chimaeric hepadnavirus core antigen proteins |
| 02/27/2001 | CA2022480C Process for cross-linking collagenous materials and resulting product |
| 02/27/2001 | CA1341192C Process for the preparation of a protein by yeasts using an inducible system, corresponding vectors and transformed strains |
| 02/27/2001 | CA1341191C Detection of neu gene expression and products |
| 02/22/2001 | WO2001013121A1 Methods for identification of compounds stimulating insulin secretion |
| 02/22/2001 | WO2001013118A2 Methods and compositions for diagnosis of hepatoma |
| 02/22/2001 | WO2001013117A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 02/22/2001 | WO2001013112A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 02/22/2001 | WO2001013106A1 System for monitoring the expression and/or location of transgenes |
| 02/22/2001 | WO2001012856A2 Analysis of sequence tags with hairpin primers |
| 02/22/2001 | WO2001012855A2 Binary encoded sequence tags |
| 02/22/2001 | WO2001012836A1 Crystal of a truncated protein construct containing a coagulation factor viii c2 domain in the presence or absence of a bound ligand and methods of use thereof |
| 02/22/2001 | WO2001012830A1 Adenoviral vectors including dna sequences encoding angiogenic inhibitors |
| 02/22/2001 | WO2001012829A2 Replication deficient baculovirus expression system |
| 02/22/2001 | WO2001012823A2 Macular degeneration diagnostics and therapeutics |
| 02/22/2001 | WO2001012816A2 Porcine endovirus gag and env and diagnostic uses thereof |
| 02/22/2001 | WO2001012814A1 Ml-236b biosynthesis-associated dna |
| 02/22/2001 | WO2001012813A1 Gene encoding merozoite protein of babesia caballi, recombinant protein obtained therefrom and utilization thereof |
| 02/22/2001 | WO2001012812A2 Baff receptor (bcma), an immunoregulatory agent |
| 02/22/2001 | WO2001012811A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/22/2001 | WO2001012810A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 02/22/2001 | WO2001012809A2 Heterodimeric vegf variants used for inhibiting angiogenesis |
| 02/22/2001 | WO2001012808A1 Novel frizzled family genes 584 |
| 02/22/2001 | WO2001012807A1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN |
| 02/22/2001 | WO2001012806A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | WO2001012805A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | WO2001012803A2 Methods and compositions for restoring antibiotic susceptibility in glycopeptide-resistant enterococcus |
| 02/22/2001 | WO2001012801A2 Defense-related signaling genes and methods of use |
| 02/22/2001 | WO2001012799A2 Regulatory sequences for pollen specific or pollen abundant gene expression in plants |
| 02/22/2001 | WO2001012798A2 Male sterile plants |
| 02/22/2001 | WO2001012797A2 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 02/22/2001 | WO2001012796A2 Pkd constructs and screening methods |
| 02/22/2001 | WO2001012786A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012784A1 METHOD FOR TREATMENT OF β-HEMOGLOBINOPATHIES |
| 02/22/2001 | WO2001012781A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | WO2001012777A2 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 02/22/2001 | WO2001012776A2 18 human secreted proteins |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012674A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | WO2001012673A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | WO2001012672A2 Cytokine receptor common gamma chain like |
| 02/22/2001 | WO2001012671A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | WO2001012670A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012669A1 Vegf-d and angiogenic use thereof |
| 02/22/2001 | WO2001012668A1 Cathelicidin-derived peptides with broad spectrum antimicrobial activity |
| 02/22/2001 | WO2001012667A1 Universal markers of transgenesis |
| 02/22/2001 | WO2001012666A1 Parvovirus ns1 variants |
| 02/22/2001 | WO2001012665A2 Helical cytokine zalpha48 |
| 02/22/2001 | WO2001012664A2 Notch receptor ligands and uses thereof |
| 02/22/2001 | WO2001012663A2 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | WO2001012662A2 Membrane associated proteins |